ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends

April 30, 1999

In Brief: GAO Says Scholarships And Loans Are Failures; Suggests Med Schools Need Facilities, Teachers

January 31, 1975

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996